$NLTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Neoleukin Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Neoleukin Therapeutics, Inc.. Get notifications about new insider transactions in Neoleukin Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 09 2017 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 16.85 | 2,442 | 41,156 | 9,423,911 | 9.4 M to 9.4 M (+0.03 %) |
Jan 09 2017 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 16.85 | 258 | 4,348 | 1,133,681 | 1.1 M to 1.1 M (+0.02 %) |
Jan 09 2017 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 15.32 | 11,305 | 173,204 | 9,421,469 | 9.4 M to 9.4 M (+0.12 %) |
Jan 09 2017 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 15.32 | 1,195 | 18,309 | 1,133,423 | 1.1 M to 1.1 M (+0.11 %) |
Jan 09 2017 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 16.74 | 5,697 | 95,365 | 9,410,164 | 9.4 M to 9.4 M (+0.06 %) |
Jan 09 2017 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 16.74 | 603 | 10,094 | 1,132,228 | 1.1 M to 1.1 M (+0.05 %) |
Nov 10 2016 | AQXP | AQUINOX PHARMACEUT ... | Troupin Barbara | Chief Medical Offic ... | Option Exercise | A | 11.77 | 50,000 | 588,500 | 50,000 | |
Sep 21 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 13.15 | 12,550 | 165,029 | 1,131,625 | 1.1 M to 1.1 M (+1.12 %) |
Sep 21 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 12.25 | 2,476,348 | 30,335,263 | 9,404,467 | 6.9 M to 9.4 M (+35.74 %) |
Sep 21 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 12.25 | 294,707 | 3,610,161 | 1,119,075 | 824.4 K to 1.1 M (+35.75 %) |
Aug 05 2016 | AQXP | AQUINOX PHARMACEUT ... | Jenkins Abigail | Chief Commercial Of ... | Option Exercise | A | 8.97 | 50,000 | 448,500 | 50,000 | |
May 11 2016 | AQXP | AQUINOX PHARMACEUT ... | Nolan Sean P. | Director | Option Exercise | A | 7.73 | 7,500 | 57,975 | 7,500 | |
May 11 2016 | AQXP | AQUINOX PHARMACEUT ... | Pelzer Robert | Director | Option Exercise | A | 7.73 | 7,500 | 57,975 | 7,500 | |
May 11 2016 | AQXP | AQUINOX PHARMACEUT ... | SIMPSON TODD E | Director | Option Exercise | A | 7.73 | 7,500 | 57,975 | 7,500 | |
May 11 2016 | AQXP | AQUINOX PHARMACEUT ... | LEVITT DANIEL J | Director | Option Exercise | A | 7.73 | 7,500 | 57,975 | 7,500 | |
May 11 2016 | AQXP | AQUINOX PHARMACEUT ... | Bridger Gary | Director | Option Exercise | A | 7.73 | 7,500 | 57,975 | 7,500 | |
Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.16 | 128,975 | 1,051,920 | 6,928,119 | 6.8 M to 6.9 M (+1.90 %) |
Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.16 | 14,046 | 114,559 | 824,368 | 810.3 K to 824.4 K (+1.73 %) |
Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.91 | 185,413 | 1,466,320 | 6,799,144 | 6.6 M to 6.8 M (+2.80 %) |
Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.91 | 20,192 | 159,686 | 810,322 | 790.1 K to 810.3 K (+2.56 %) |
Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.70 | 11,840 | 91,160 | 6,613,731 | 6.6 M to 6.6 M (+0.18 %) |
Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.70 | 1,289 | 9,924 | 790,130 | 788.8 K to 790.1 K (+0.16 %) |
Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.03 | 68,132 | 546,807 | 6,601,891 | 6.5 M to 6.6 M (+1.04 %) |
Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.03 | 7,420 | 59,551 | 788,841 | 781.4 K to 788.8 K (+0.95 %) |
Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.88 | 30,986 | 244,126 | 6,533,759 | 6.5 M to 6.5 M (+0.48 %) |
Mar 16 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.88 | 3,374 | 26,582 | 781,421 | 778 K to 781.4 K (+0.43 %) |
Mar 14 2016 | AQXP | AQUINOX PHARMACEUT ... | SHREWSBURY STEPHEN B | CMO; Senior VP Clin ... | Option Exercise | A | 8.08 | 35,000 | 282,800 | 35,000 | |
Mar 14 2016 | AQXP | AQUINOX PHARMACEUT ... | Mitchell David Chilton | VP Global Regulator ... | Option Exercise | A | 8.08 | 25,000 | 202,000 | 25,000 | |
Mar 14 2016 | AQXP | AQUINOX PHARMACEUT ... | Main David | President and CEO | Option Exercise | A | 8.08 | 120,000 | 969,600 | 120,000 | |
Mar 14 2016 | AQXP | AQUINOX PHARMACEUT ... | MacKenzie Lloyd | VP Technical Operat ... | Option Exercise | A | 8.08 | 35,000 | 282,800 | 35,000 | |
Mar 14 2016 | AQXP | AQUINOX PHARMACEUT ... | Alam Kamran | CFO, Vice President ... | Option Exercise | A | 8.08 | 40,000 | 323,200 | 40,000 | |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.00 | 3,581 | 39,377 | 6,502,773 | 6.5 M to 6.5 M (+0.06 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.00 | 395 | 4,343 | 778,047 | 777.7 K to 778 K (+0.05 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.80 | 66,345 | 716,745 | 6,499,192 | 6.4 M to 6.5 M (+1.03 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.80 | 7,318 | 79,059 | 777,652 | 770.3 K to 777.7 K (+0.95 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.20 | 2,522 | 28,257 | 6,432,847 | 6.4 M to 6.4 M (+0.04 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.20 | 278 | 3,115 | 770,334 | 770.1 K to 770.3 K (+0.04 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.98 | 4,503 | 49,423 | 6,430,325 | 6.4 M to 6.4 M (+0.07 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.98 | 497 | 5,455 | 770,056 | 769.6 K to 770.1 K (+0.06 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.23 | 2,833 | 31,822 | 6,425,822 | 6.4 M to 6.4 M (+0.04 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 11.23 | 312 | 3,505 | 769,559 | 769.2 K to 769.6 K (+0.04 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.69 | 25,650 | 274,219 | 6,422,989 | 6.4 M to 6.4 M (+0.40 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.69 | 2,810 | 30,041 | 769,247 | 766.4 K to 769.2 K (+0.37 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.60 | 156 | 1,654 | 6,397,339 | 6.4 M to 6.4 M (0.00 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.60 | 17 | 180 | 766,437 | 766.4 K to 766.4 K (0.00 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.69 | 4,021 | 42,999 | 6,397,183 | 6.4 M to 6.4 M (+0.06 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.69 | 440 | 4,705 | 766,420 | 766 K to 766.4 K (+0.06 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.78 | 17,221 | 185,666 | 6,393,162 | 6.4 M to 6.4 M (+0.27 %) |
Jan 26 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 10.78 | 1,887 | 20,345 | 765,980 | 764.1 K to 766 K (+0.25 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.90 | 1,734 | 15,433 | 6,375,941 | 6.4 M to 6.4 M (+0.03 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.90 | 190 | 1,691 | 764,093 | 763.9 K to 764.1 K (+0.02 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.96 | 27,996 | 250,766 | 6,374,207 | 6.3 M to 6.4 M (+0.44 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.96 | 3,067 | 27,472 | 763,903 | 760.8 K to 763.9 K (+0.40 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.96 | 13,789 | 123,493 | 6,346,211 | 6.3 M to 6.3 M (+0.22 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.96 | 1,511 | 13,532 | 760,836 | 759.3 K to 760.8 K (+0.20 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.89 | 57,453 | 567,934 | 6,332,422 | 6.3 M to 6.3 M (+0.92 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.89 | 6,294 | 62,217 | 759,325 | 753 K to 759.3 K (+0.84 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.15 | 14,313 | 131,017 | 6,274,969 | 6.3 M to 6.3 M (+0.23 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.15 | 1,568 | 14,353 | 753,031 | 751.5 K to 753 K (+0.21 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.21 | 10,123 | 93,282 | 6,260,656 | 6.3 M to 6.3 M (+0.16 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.21 | 1,109 | 10,219 | 751,463 | 750.4 K to 751.5 K (+0.15 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.08 | 45,903 | 416,602 | 6,250,533 | 6.2 M to 6.3 M (+0.74 %) |
Jan 20 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 9.08 | 5,029 | 45,642 | 750,354 | 745.3 K to 750.4 K (+0.67 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.56 | 47,193 | 403,930 | 6,204,630 | 6.2 M to 6.2 M (+0.77 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.56 | 5,196 | 44,473 | 745,325 | 740.1 K to 745.3 K (+0.70 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.95 | 4,949 | 44,308 | 6,157,437 | 6.2 M to 6.2 M (+0.08 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.95 | 545 | 4,879 | 740,129 | 739.6 K to 740.1 K (+0.07 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.82 | 3,279 | 28,937 | 6,152,488 | 6.1 M to 6.2 M (+0.05 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.82 | 361 | 3,186 | 739,584 | 739.2 K to 739.6 K (+0.05 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.10 | 20,851 | 168,891 | 6,149,209 | 6.1 M to 6.1 M (+0.34 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.10 | 2,296 | 18,597 | 739,223 | 736.9 K to 739.2 K (+0.31 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.08 | 2,998 | 24,213 | 6,128,358 | 6.1 M to 6.1 M (+0.05 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.08 | 330 | 2,665 | 736,927 | 736.6 K to 736.9 K (+0.04 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.91 | 12,706 | 100,517 | 6,125,360 | 6.1 M to 6.1 M (+0.21 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 7.91 | 1,399 | 11,067 | 736,597 | 735.2 K to 736.6 K (+0.19 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.17 | 90,550 | 739,947 | 6,112,654 | 6 M to 6.1 M (+1.50 %) |
Jan 15 2016 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 8.17 | 9,970 | 81,472 | 735,198 | 725.2 K to 735.2 K (+1.37 %) |
Nov 03 2015 | AQXP | AQUINOX PHARMACEUT ... | Bridger Gary | Director | Sell | J | 0.00 | 1,543,989 | 0 | 0 | 1.5 M to 0 (-100.00 %) |
Sep 11 2015 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 15.50 | 2,213,469 | 34,308,770 | 6,022,104 | 3.8 M to 6 M (+58.12 %) |
Sep 11 2015 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 15.50 | 266,563 | 4,131,727 | 725,228 | 458.7 K to 725.2 K (+58.12 %) |
Aug 26 2015 | AQXP | AQUINOX PHARMACEUT ... | Mitchell David Chilton | VP Global Regulator ... | Buy | P | 17.81 | 3,575 | 63,671 | 3,575 | 0 to 3.6 K |
Aug 14 2015 | AQXP | AQUINOX PHARMACEUT ... | MacKenzie Lloyd | VP Technical Operat ... | Option Exercise | M | 5.76 | 28,075 | 161,712 | 1,872 | |
Aug 14 2015 | AQXP | AQUINOX PHARMACEUT ... | MacKenzie Lloyd | VP Technical Operat ... | Option Exercise | M | 5.76 | 7,812 | 44,997 | 0 | |
Aug 14 2015 | AQXP | AQUINOX PHARMACEUT ... | MacKenzie Lloyd | VP Technical Operat ... | Sell | S | 18.67 | 35,887 | 670,010 | 0 | 35.9 K to 0 (-100.00 %) |
Aug 14 2015 | AQXP | AQUINOX PHARMACEUT ... | MacKenzie Lloyd | VP Technical Operat ... | Buy | M | 5.76 | 28,075 | 161,712 | 35,887 | 7.8 K to 35.9 K (+359.38 %) |
Aug 14 2015 | AQXP | AQUINOX PHARMACEUT ... | MacKenzie Lloyd | VP Technical Operat ... | Buy | M | 5.76 | 7,812 | 44,997 | 7,812 | 0 to 7.8 K |
Aug 14 2015 | AQXP | AQUINOX PHARMACEUT ... | Alam Kamran | CFO, Vice President ... | Option Exercise | M | 5.76 | 20,833 | 119,998 | 0 | |
Aug 14 2015 | AQXP | AQUINOX PHARMACEUT ... | Alam Kamran | CFO, Vice President ... | Option Exercise | M | 5.76 | 8,246 | 47,497 | 2,170 | |
Aug 14 2015 | AQXP | AQUINOX PHARMACEUT ... | Alam Kamran | CFO, Vice President ... | Sell | S | 18.67 | 29,079 | 542,905 | 0 | 29.1 K to 0 (-100.00 %) |
Aug 14 2015 | AQXP | AQUINOX PHARMACEUT ... | Alam Kamran | CFO, Vice President ... | Buy | M | 5.76 | 20,833 | 119,998 | 29,079 | 8.2 K to 29.1 K (+252.64 %) |
Aug 14 2015 | AQXP | AQUINOX PHARMACEUT ... | Alam Kamran | CFO, Vice President ... | Buy | M | 5.76 | 8,246 | 47,497 | 8,246 | 0 to 8.2 K |
Aug 13 2015 | AQXP | AQUINOX PHARMACEUT ... | Mitchell David Chilton | VP Global Regulator ... | Buy | P | 24.36 | 1,600 | 38,976 | 1,600 | 0 to 1.6 K |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 23.41 | 58,632 | 1,372,645 | 975,403 | 1 M to 975.4 K (-5.67 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 22.60 | 44,268 | 1,000,430 | 1,034,035 | 1.1 M to 1 M (-4.11 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 24.31 | 31,400 | 763,425 | 1,078,303 | 1.1 M to 1.1 M (-2.83 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 20.35 | 25,931 | 527,634 | 1,109,703 | 1.1 M to 1.1 M (-2.28 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 26.32 | 13,109 | 345,046 | 1,135,634 | 1.1 M to 1.1 M (-1.14 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 25.32 | 12,726 | 322,264 | 1,148,743 | 1.2 M to 1.1 M (-1.10 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 38.49 | 11,627 | 447,578 | 1,161,469 | 1.2 M to 1.2 M (-0.99 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 36.37 | 10,544 | 383,472 | 1,173,096 | 1.2 M to 1.2 M (-0.89 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 37.23 | 9,901 | 368,579 | 1,183,640 | 1.2 M to 1.2 M (-0.83 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 39.52 | 9,142 | 361,266 | 1,193,541 | 1.2 M to 1.2 M (-0.76 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 21.45 | 8,969 | 192,390 | 1,202,683 | 1.2 M to 1.2 M (-0.74 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 27.36 | 8,565 | 234,305 | 1,211,652 | 1.2 M to 1.2 M (-0.70 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 40.30 | 6,073 | 244,715 | 1,220,217 | 1.2 M to 1.2 M (-0.50 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 35.61 | 3,207 | 114,192 | 1,226,290 | 1.2 M to 1.2 M (-0.26 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 28.47 | 2,975 | 84,689 | 1,229,497 | 1.2 M to 1.2 M (-0.24 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 41.25 | 2,840 | 117,143 | 1,232,472 | 1.2 M to 1.2 M (-0.23 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | PFIZER INC | 10% Owner | Sell | S | 29.00 | 18 | 522 | 1,235,312 | 1.2 M to 1.2 M (0.00 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 20.74 | 1,283,366 | 26,617,011 | 100,000 | 1.4 M to 100 K (-92.77 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 31.66 | 231,455 | 7,327,865 | 1,383,366 | 1.6 M to 1.4 M (-14.33 %) |
Mar 16 2015 | AQXP | AQUINOX PHARMACEUT ... | Nolan Sean P. | Director | Option Exercise | A | 12.03 | 10,000 | 120,300 | 10,000 | |
Mar 16 2015 | AQXP | AQUINOX PHARMACEUT ... | MacKenzie Lloyd | VP Technical Operat ... | Option Exercise | A | 12.03 | 25,000 | 300,750 | 25,000 | |
Mar 16 2015 | AQXP | AQUINOX PHARMACEUT ... | LEVITT DANIEL J | Director | Option Exercise | A | 12.03 | 5,000 | 60,150 | 5,000 | |
Mar 16 2015 | AQXP | AQUINOX PHARMACEUT ... | Bridger Gary | Director | Option Exercise | A | 12.03 | 5,000 | 60,150 | 5,000 | |
Mar 16 2015 | AQXP | AQUINOX PHARMACEUT ... | Alam Kamran | CFO, Vice President ... | Option Exercise | A | 12.03 | 25,000 | 300,750 | 25,000 | |
Mar 16 2015 | AQXP | AQUINOX PHARMACEUT ... | SIMPSON TODD E | Director | Option Exercise | A | 12.03 | 5,000 | 60,150 | 5,000 | |
Mar 16 2015 | AQXP | AQUINOX PHARMACEUT ... | SHREWSBURY STEPHEN B | CMO; Senior VP Clin ... | Option Exercise | A | 12.03 | 25,000 | 300,750 | 25,000 | |
Mar 16 2015 | AQXP | AQUINOX PHARMACEUT ... | Pelzer Robert | Director | Option Exercise | A | 12.03 | 5,000 | 60,150 | 5,000 | |
Mar 16 2015 | AQXP | AQUINOX PHARMACEUT ... | Main David | President and CEO | Option Exercise | A | 12.03 | 65,000 | 781,950 | 65,000 | |
Jan 13 2015 | AQXP | AQUINOX PHARMACEUT ... | Mitchell David Chilton | VP Global Regulator ... | Option Exercise | A | 9.51 | 35,000 | 332,850 | 35,000 | |
Dec 18 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.58 | 1,593 | 12,075 | 1,342,094 | 1.3 M to 1.3 M (-0.12 %) |
Dec 18 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.63 | 6,507 | 49,648 | 1,343,687 | 1.4 M to 1.3 M (-0.48 %) |
Dec 15 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.51 | 3,645 | 27,374 | 1,350,194 | 1.4 M to 1.4 M (-0.27 %) |
Dec 15 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.50 | 1,355 | 10,163 | 1,353,839 | 1.4 M to 1.4 M (-0.10 %) |
Dec 10 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.70 | 1,300 | 10,010 | 1,355,194 | 1.4 M to 1.4 M (-0.10 %) |
Dec 10 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.73 | 5,000 | 38,650 | 1,356,494 | 1.4 M to 1.4 M (-0.37 %) |
Dec 10 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.69 | 2,000 | 15,380 | 1,361,494 | 1.4 M to 1.4 M (-0.15 %) |
Dec 05 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.78 | 4,200 | 32,676 | 1,363,494 | 1.4 M to 1.4 M (-0.31 %) |
Dec 05 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.76 | 10,073 | 78,166 | 1,367,694 | 1.4 M to 1.4 M (-0.73 %) |
Dec 05 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.75 | 1,627 | 12,609 | 1,377,767 | 1.4 M to 1.4 M (-0.12 %) |
Dec 03 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.54 | 1,200 | 9,048 | 1,379,394 | 1.4 M to 1.4 M (-0.09 %) |
Nov 26 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.60 | 500 | 3,800 | 1,380,594 | 1.4 M to 1.4 M (-0.04 %) |
Nov 26 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.80 | 1,500 | 11,700 | 1,381,094 | 1.4 M to 1.4 M (-0.11 %) |
Nov 24 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 8.02 | 4,000 | 32,080 | 1,382,594 | 1.4 M to 1.4 M (-0.29 %) |
Nov 24 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 8.25 | 2,400 | 19,800 | 1,386,594 | 1.4 M to 1.4 M (-0.17 %) |
Nov 24 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 8.21 | 3,100 | 25,451 | 1,388,994 | 1.4 M to 1.4 M (-0.22 %) |
May 12 2014 | AQXP | AQUINOX PHARMACEUT ... | SHREWSBURY STEPHEN B | CMO; Senior VP Clin ... | Option Exercise | A | 10.10 | 31,250 | 315,625 | 31,250 | |
May 12 2014 | AQXP | AQUINOX PHARMACEUT ... | Main David | President and CEO | Option Exercise | A | 10.10 | 65,000 | 656,500 | 65,000 | |
May 12 2014 | AQXP | AQUINOX PHARMACEUT ... | MacKenzie Lloyd | VP Technical Operat ... | Option Exercise | A | 10.10 | 25,000 | 252,500 | 25,000 | |
May 12 2014 | AQXP | AQUINOX PHARMACEUT ... | Alam Kamran | CFO, Vice President ... | Option Exercise | A | 10.10 | 31,250 | 315,625 | 31,250 | |
Mar 14 2014 | AQXP | AQUINOX PHARMACEUT ... | Ventures West 8 Limited Partne ... | 10% Owner | Option Exercise | C | 0.00 | 378,786 | 0 | 0 | |
Mar 14 2014 | AQXP | AQUINOX PHARMACEUT ... | Ventures West 8 Limited Partne ... | 10% Owner | Option Exercise | C | 0.00 | 378,786 | 0 | 0 | |
Mar 14 2014 | AQXP | AQUINOX PHARMACEUT ... | Ventures West 8 Limited Partne ... | 10% Owner | Option Exercise | C | 0.00 | 378,786 | 0 | 0 | |
Mar 14 2014 | AQXP | AQUINOX PHARMACEUT ... | Ventures West 8 Limited Partne ... | 10% Owner | Option Exercise | C | 0.00 | 325,035 | 0 | 0 | |
Mar 14 2014 | AQXP | AQUINOX PHARMACEUT ... | Ventures West 8 Limited Partne ... | 10% Owner | Option Exercise | C | 0.00 | 325,035 | 0 | 0 | |
Mar 14 2014 | AQXP | AQUINOX PHARMACEUT ... | Ventures West 8 Limited Partne ... | 10% Owner | Option Exercise | C | 0.00 | 325,035 | 0 | 0 | |
Mar 14 2014 | AQXP | AQUINOX PHARMACEUT ... | Ventures West 8 Limited Partne ... | 10% Owner | Option Exercise | C | 0.00 | 326,538 | 0 | 0 | |
Mar 14 2014 | AQXP | AQUINOX PHARMACEUT ... | Ventures West 8 Limited Partne ... | 10% Owner | Option Exercise | C | 0.00 | 326,538 | 0 | 0 | |
Mar 14 2014 | AQXP | AQUINOX PHARMACEUT ... | Ventures West 8 Limited Partne ... | 10% Owner | Option Exercise | C | 0.00 | 326,538 | 0 | 0 |